- Business Wire•4 days ago
bluebird bio, Inc. , a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, today announced that Derek Adams, Ph.D.
- MarketWatch•8 days ago
Harry Boxer is tracking bluebird bio, Clovis Oncology and Boingo Wireless.
- Motley Fool•18 days ago
Several of the most interesting drugs in development belong to Bellicum and bluebird bio, but which is the better stock pick right now?
BLUE : Summary for bluebird bio, Inc. - Yahoo Finance
bluebird bio, Inc. (BLUE)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||78.40 x 100|
|Day's Range||86.55 - 91.25|
|52 Week Range||35.37 - 100.40|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-12.30|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|